PRACTICING TO THE TOP SCOPE OF UROLOGY PRACTICE AND ADVANCING TREATMENT AND PATIENT CARE THROUGH RESEARCH
People In Health Care Segment
Filmed in Melbourne | March 2025
With
Michael Cromer,
Urology Nurse Practitioner
Australian Prostate Cancer (APC) & Western Urology,
Melbourne
Michael is a urology nurse practitioner with a special interest in prostate cancer survivorship, and has worked in urology for the past ten years. Michael has completed the Prostate Nursing Care course at Latrobe University, Graduate Certificate of Health with a specialisation in Scheduled Medicines (USQ), and the Master of Nursing (Flinders) to become a Nurse Practitioner in 2024.
As a Urology Nurse Practitioner he divides his time between the Australian Prostate Centre and Western Urology.
He also has particular interest in sexual function, continence management and procedures under local anaesthetic. Currently Michael is involved in several research projects relating to prostate cancer testing and treatment, BPH and sexual function.
Michael is a member of the Australia & New Zealand Urological Nurses Society (ANZUNS), Victorian Urological Nurses Society (VUNS), and the Australian College of Nursing (ACN).
Source: supplied and edited
-
WA and QLD RSV Immunisation programs show drops in infant hospitalisations
RSV is the number one cause of hospitalisation of Australian children under five years of age, according to the Immunisation Foundation of Australia (IFA). There are mounting concerns that Australians at greatest risk of severe Respiratory Syncytial Virus, or RSV will miss out on protection against the lung infection, with the Federal Government failing to commit to a national RSV immunisation program.
-
Study: First time stroke survivors have substantial immediate and accelerated long term cognitive decline
New evidence from the Centre for Healthy Brain Ageing (CHeBA) indicates that older adults who experience a stroke for the first time will have substantial immediate and accelerated long term-cognitive decline.
-
Report gives insights to clinical trial activity in Australia
Established in 2024, Bellberry is a Adelaide-based national, not-for-profit organisation that provides streamlined scientific and ethical reviews of human research. It is the 2025 winner of the Championing Health Award in the Telstra Best of Business Awards.
Australian Health Journal spoke with Bellberry Limited CEO, Kylie Sproston on the organisation and the findings in activity documented in the Clinical Trial Activity Report (CTAR) 2024.
